使用Player FM应用程序离线!
From the helm: Immutep's (ASX:IMM) Executive Director & CEO Marc Voigt
Manage episode 301433196 series 2611018
In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Immutep's (ASX:IMM) Executive Director and CEO, Marc Voigt.
Immutep has gained a lot of attention, as its trials in collaboration with big-names, Pfizer and Merck, has seen a remission in patients' tumours. Between capital raisings and partnerships, Immutep continues to deliver impressive results...
In this video Marc discusses:
- (0:40) IMM's progress: the year that was, and the year ahead
- (1:30) Promising results from an IMM study in collaboration with Pfizer and Merck
- (2:29) Its unique discovery in immunotherapy - which spells new opportunities
- (4:02) Key catalysts that could drive share price growth
- (6:00) Fund managers who bought into IMM recently - and how funds raised will be spent
This interview was filmed on 18 August 2021.
57集单集
Manage episode 301433196 series 2611018
In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Immutep's (ASX:IMM) Executive Director and CEO, Marc Voigt.
Immutep has gained a lot of attention, as its trials in collaboration with big-names, Pfizer and Merck, has seen a remission in patients' tumours. Between capital raisings and partnerships, Immutep continues to deliver impressive results...
In this video Marc discusses:
- (0:40) IMM's progress: the year that was, and the year ahead
- (1:30) Promising results from an IMM study in collaboration with Pfizer and Merck
- (2:29) Its unique discovery in immunotherapy - which spells new opportunities
- (4:02) Key catalysts that could drive share price growth
- (6:00) Fund managers who bought into IMM recently - and how funds raised will be spent
This interview was filmed on 18 August 2021.
57集单集
Tất cả các tập
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。